<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To assess the implementation of St </plain></SENT>
<SENT sid="1" pm="."><plain>Vincent recommendations in Catalonia (Spain) between 1993 and 2003 following a program of Continuous Quality Improvement </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: 65 health centres (433 health professionals) took part in the study </plain></SENT>
<SENT sid="3" pm="."><plain>From 1993 to 2003, 34 workshops on consensus guidelines and feedback referring to the variables that needed to be improved were carried out </plain></SENT>
<SENT sid="4" pm="."><plain>Data collection was obtained concerning, socio-demographic information, and disease characteristics and complications from patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Most <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> improved: glycosilated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> (HbA1c) was reduced by 0.7% (95% CI: -0.49:-0.90); total cholesterol by 0.54mmol/L (95% CI: -0.53:-0.55); non-<z:chebi fb="1" ids="47775">high density lipoprotein cholesterol</z:chebi> by 0.81mmol/L (95% CI: -0.80:-0.82); systolic blood pressure (SBP) by 6.02mmHg (95% CI: -5.79:-6.25), and diastolic blood pressure (<z:chebi fb="4" ids="35861">DBP</z:chebi>) by 2.65mmHg (95% CI: -2.4:-2.9), with the exception of smoking and <z:hpo ids='HP_0001513'>obesity</z:hpo>, which increased by 2.1% and 5.9%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000488'>Retinopathy</z:hpo> and <z:mp ids='MP_0002871'>albuminuria</z:mp> decreased by 40.7% and 46% (p&lt;0.001), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of <z:e sem="disease" ids="C0206172" disease_type="Disease or Syndrome" abbrv="">diabetic foot</z:e> lesions and <z:mpath ids='MPATH_686'>amputations</z:mpath> decreased by 65.7% and 61.1% (p&lt;0.001), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The prevalence of macrovascular complications showed a slight reduction (p=0.037) </plain></SENT>
<SENT sid="9" pm="."><plain>Ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo> decreased by 7.7% and 17.6%, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our Continuous Quality Improvement program based on St </plain></SENT>
<SENT sid="11" pm="."><plain>Vincent recommendations, had a positive impact on <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>We observed a reduction of <z:hpo ids='HP_0011010'>chronic</z:hpo> complications in type 2 DM patients </plain></SENT>
</text></document>